International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium

We leveraged the largely untapped resource of electronic health record data to address critical clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To do this, we formed an international consortium (4CE) of 96 hospitals across five countries ( www.covidclinical.net ). Contributors utilized the Informatics for Integrating Biology and the Bedside (i2b2) or Observational Medical Outcomes Partnership (OMOP) platforms to map to a common data model. The group focused on temporal changes in key laboratory test values. Harmonized data were analyzed locally and converted to a shared aggregate form for rapid analysis and visualization of regional differences and global commonalities. Data covered 27,584 COVID-19 cases with 187,802 laboratory tests. Case counts and laboratory trajectories were concordant with existing literature. Laboratory tests at the time of diagnosis showed hospital-level differences equivalent to country-level variation across the consortium partners. Despite the limitations of decentralized data generation, we established a framework to capture the trajectory of COVID-19 disease in patients and their response to interventions.

[1]  Olivier Bodenreider,et al.  The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..

[2]  Catherine Moore,et al.  Case Report: Standardizing Laboratory Data by Mapping to LOINC , 2006, J. Am. Medical Informatics Assoc..

[3]  F. Schmidt.  Meta-Analysis , 2008 .

[4]  Douglas MacFadden,et al.  Application of Information Technology The Shared Health Research Information Network ( SHRINE ) : A Prototype Federated Query Tool for Clinical Data Repositories , 2014 .

[5]  Griffin M. Weber,et al.  Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) , 2010, J. Am. Medical Informatics Assoc..

[6]  Isaac S. Kohane,et al.  A translational engine at the national scale: informatics for integrating biology and the bedside , 2012, J. Am. Medical Informatics Assoc..

[7]  Daniel J. Vreeman,et al.  Impact of Selective Mapping Strategies on Automated Laboratory Result Notification to Public Health Authorities , 2012, AMIA.

[8]  Douglas MacFadden,et al.  SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies , 2013, PloS one.

[9]  Daniel J. Vreeman,et al.  Evaluating Congruence Between Laboratory LOINC Value Sets for Quality Measures, Public Health Reporting, and Mapping Common Tests , 2013, AMIA.

[10]  S. Kimmel.  Architecture , 2013, Arsham-isms.

[11]  Xiaobo Zhou,et al.  Scalable Collaborative Infrastructure for a Learning Healthcare System (SCILHS): Architecture , 2014, J. Am. Medical Informatics Assoc..

[12]  Richard Platt,et al.  Launching PCORnet, a national patient-centered clinical research network , 2014, Journal of the American Medical Informatics Association : JAMIA.

[13]  Isaac S. Kohane,et al.  Informatics for Integrating Biology and the Bedside (I2b2) Clinical Trials (CT) Patient Ascertainment Suite , 2014, AMIA.

[14]  Brian E Dixon,et al.  Learning From the Crowd in Terminology Mapping: The LOINC Experience. , 2015, Laboratory medicine.

[15]  Tiina K. Urv,et al.  Early Vision for the CTSA Program Trial Innovation Network: A Perspective from the National Center for Advancing Translational Sciences , 2017, Clinical and translational science.

[16]  Daniel J. Vreeman,et al.  Recent Developments in Clinical Terminologies — SNOMED CT, LOINC, and RxNorm , 2018, Yearbook of Medical Informatics.

[17]  I. Kohane,et al.  Rcupcake: an R package for querying and analyzing biomedical data through the BD2K PIC-SURE RESTful API , 2017, Bioinform..

[18]  Shyam Visweswaran,et al.  Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network , 2018, JAMIA open.

[19]  S. Semler,et al.  German Medical Informatics Initiative , 2018, Methods of Information in Medicine.

[20]  Keith Marsolo,et al.  The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system , 2019, Genetics in Medicine.

[21]  Mario Plebani,et al.  Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.

[22]  G. Heinze,et al.  Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.

[23]  Xiu-Wu Pan,et al.  Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis , 2020, Intensive Care Medicine.

[24]  J. Thachil,et al.  The versatile heparin in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[25]  Cdc Covid- Response Team.  Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 — United States, February 12–March 28, 2020 , 2020 .

[26]  Chao Zhang,et al.  Liver injury in COVID-19: management and challenges , 2020, The Lancet Gastroenterology & Hepatology.

[27]  Emily N. Ussery,et al.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[28]  Q. Tong,et al.  Rhabdomyolysis as Potential Late Complication Associated with COVID-19 , 2020, Emerging infectious diseases.

[29]  L. Rostaing,et al.  Why the immune system fails to mount an adaptive immune response to a COVID‐19 infection , 2020, Transplant international : official journal of the European Society for Organ Transplantation.

[30]  Mario Plebani,et al.  Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis , 2020, Clinica Chimica Acta.

[31]  Jinoos Yazdany,et al.  The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic , 2020, Nature Reviews Rheumatology.

[32]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[33]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[34]  G. Fonarow,et al.  Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. , 2020, JAMA cardiology.

[35]  Ahmed Nabih Zaki Rashed.  Overview of Data Collection and Analysis , 2021 .